Skip to main content
UofA JBI Logo

Main navigation

  • Home
  • About JBI
    • About
      • Annual Reports
      • Our History
    • JBI Model of EBHC
    • JBI Impact
  • Global Reach
    • JBI COLLABORATION
    • GROUPS WE WORK WITH
    • JBI ENDORSEMENT
  • Education
    • Short Courses
      • Comprehensive Systematic Review Training Program
      • Evidence Implementation Training Program
      • Evidence Implementation Workshop
      • Clinical Leadership Workshop
      • Scoping Review Workshop
      • GRADE Workshop
    • Post Graduate Research Degrees
      • Master of Clinical Science
      • Doctor of Philosophy
    • Tailored Training
  • Products & Services
    • JBI EBP Database
    • Journals
    • Software
    • Consultancy
    • Systematic Review Register
  • EBP Resources
    • COVID-19 Special Collection
    • Critical Appraisal Tools
    • JBI Manual for Evidence Synthesis
    • JBI Manual for Evidence Implementation
    • JBI SUMARI Knowledge Base
    • JBI PACES Knowledge Base
    • JBI Live Webinars
    • Scoping Review Network
    • Ask JBI
  • News & Events
    • NEWS
      • JBI News
      • JBI Buzz
    • EVENTS
      • JBI Events
      • Global Events
      • Solution Room
  • Home
  • About JBI
    • About
      • Annual Reports
      • Our History
    • JBI Model of EBHC
    • JBI Impact
  • Global Reach
    • JBI COLLABORATION
    • GROUPS WE WORK WITH
    • JBI ENDORSEMENT
  • Education
    • Short Courses
      • Comprehensive Systematic Review Training Program
      • Evidence Implementation Training Program
      • Evidence Implementation Workshop
      • Clinical Leadership Workshop
      • Scoping Review Workshop
      • GRADE Workshop
    • Post Graduate Research Degrees
      • Master of Clinical Science
      • Doctor of Philosophy
    • Tailored Training
  • Products & Services
    • JBI EBP Database
    • Journals
    • Software
    • Consultancy
    • Systematic Review Register
  • EBP Resources
    • COVID-19 Special Collection
    • Critical Appraisal Tools
    • JBI Manual for Evidence Synthesis
    • JBI Manual for Evidence Implementation
    • JBI SUMARI Knowledge Base
    • JBI PACES Knowledge Base
    • JBI Live Webinars
    • Scoping Review Network
    • Ask JBI
  • News & Events
    • NEWS
      • JBI News
      • JBI Buzz
    • EVENTS
      • JBI Events
      • Global Events
      • Solution Room
 

Breadcrumb

  1. Home
  2. 2581
Collaborating Entity
Kalam Institute of Health Technology: A JBI Affiliated Group
Name
Dr. Kavita Kachroo
eMail
[email protected]
Question

What is the Clinical Effectiveness of orphan drugs  in Covid-19 patients when compared with Standard Care?

Population

Covid-19 Patients
According to World Heath Organisation on 16th August 2021, there have beern 207,173,086 confirmed cases of Covid-19, including 4,361,996 deaths, reported to WHO. Where as in India 16th August 2021, there have been 32,225,513 confirmed cases of Covid-19 with 431,642 deaths,reported to WHO.

Intervention
Intervention (quantitative - effectiveness)
Intervention Description

Orphan Drugs
An Orphan Drug is a Pharmaceutical agent that is used to treat a rare medical condition. Orphan Drugs which are used in Covid-19 like Anakinra, Bevacizumab, Sargramostim, Nitazoxanide, Barcitinib.

Comparator
Comparator (quantitative - effectiveness)
Comparator Description

Standard Treatment
The standard treatment like (Paracetamol, Naproxen, Ivermectin, hydroxychloroquine, steroids, budisonide, Anti-tussive, Anticoagulant, Anti-inflammatory /immunomodulatory therapy) fails in decreasing the viral load.

Outcome
Outcome & Context (comprehensive)
Outcome Description

Primary Outcome: Mortality
Secondary Outcome: Orphan Drugs (Clinical Effectiveness)

regtitle datecreated
Wed, 08/25/2021 - 09:50
regtitle dateupdated
Wed, 08/25/2021 - 09:50
connect with us
connect with us
UOA LOGO
JBI Logo
CONTACT JBI
JBI
Faculty of Health and Medical Sciences
The University of Adelaide
SA 5006 Adelaide
Australia
+61 8 8313 4880
[email protected]
 
 
 
 
LEGAL LINKS
CRICOS Provider Number 00123M
Privacy Statement
Copyright
‌ ‌ ‌ ‌ ‌ ‌
SUBSCRIBE to JBI BUZZ